Wan W, Zhou J, Ha X, Han C
Nanomedicine (Lond). 2024; 20(1):79-89.
PMID: 39639651
PMC: 11703351.
DOI: 10.1080/17435889.2024.2435255.
Liu D, Yang A, Li Y, Li Z, You P, Zhang H
J Pharm Anal. 2024; 14(9):100937.
PMID: 39345941
PMC: 11437771.
DOI: 10.1016/j.jpha.2024.01.005.
Chen W, Liu L, Tang M, Li J, Yuan W, Yin D
Mater Today Bio. 2024; 28:101162.
PMID: 39175654
PMC: 11339061.
DOI: 10.1016/j.mtbio.2024.101162.
Kar S, Das S, Kundu S, Sahu B, Kumar K, Kesari K
ACS Appl Bio Mater. 2024; 7(5):3061-3085.
PMID: 38581388
PMC: 11530090.
DOI: 10.1021/acsabm.4c00102.
Shemarova I
Int J Mol Sci. 2023; 24(21).
PMID: 37958665
PMC: 10650855.
DOI: 10.3390/ijms242115682.
Enhancement of the anti-microbial activity of essential oil on storage by glycerosomes.
Taheri S, Varshosaz J
Food Sci Biotechnol. 2023; 32(14):2145-2152.
PMID: 37860731
PMC: 10581991.
DOI: 10.1007/s10068-023-01301-5.
Recent Advances in Anti-Atherosclerosis and Potential Therapeutic Targets for Nanomaterial-Derived Drug Formulations.
Xiao Z, Li Y, Xiong L, Liao J, Gao Y, Luo Y
Adv Sci (Weinh). 2023; 10(29):e2302918.
PMID: 37698552
PMC: 10582432.
DOI: 10.1002/advs.202302918.
Nanosystems in Cardiovascular Medicine: Advancements, Applications, and Future Perspectives.
Omidian H, Babanejad N, Cubeddu L
Pharmaceutics. 2023; 15(7).
PMID: 37514121
PMC: 10386572.
DOI: 10.3390/pharmaceutics15071935.
Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2.
Azizogli A, Pai V, Coppola F, Jafari R, Dodd-O J, Harish R
ACS Omega. 2023; 8(6):5349-5360.
PMID: 36798146
PMC: 9923439.
DOI: 10.1021/acsomega.2c06384.
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines.
Namiot E, Sokolov A, Chubarev V, Tarasov V, Schioth H
Int J Mol Sci. 2023; 24(1).
PMID: 36614230
PMC: 9821409.
DOI: 10.3390/ijms24010787.
Nanoparticles in Drug Delivery: From History to Therapeutic Applications.
Afzal O, Altamimi A, Nadeem M, Alzarea S, Almalki W, Tariq A
Nanomaterials (Basel). 2022; 12(24).
PMID: 36558344
PMC: 9781272.
DOI: 10.3390/nano12244494.
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications.
Huang K, Zapata D, Tang Y, Teng Y, Li Y
Biomaterials. 2022; 291:121876.
PMID: 36334354
PMC: 10018374.
DOI: 10.1016/j.biomaterials.2022.121876.
Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction.
Lv Q, Ma B, Li W, Fu G, Wang X, Xiao Y
Front Chem. 2022; 10:943009.
PMID: 35873037
PMC: 9301085.
DOI: 10.3389/fchem.2022.943009.
Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease.
Fan C, Joshi J, Li F, Xu B, Khan M, Yang J
Front Bioeng Biotechnol. 2020; 8:687.
PMID: 32671049
PMC: 7326780.
DOI: 10.3389/fbioe.2020.00687.
Evaluation of upconverting nanoparticles towards heart theranostics.
Kermorgant M, Salem J, Santelli J, Calise D, Oster A, Lairez O
PLoS One. 2019; 14(12):e0225729.
PMID: 31815963
PMC: 6901177.
DOI: 10.1371/journal.pone.0225729.
The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis.
Mahdavi Gorabi A, Kiaie N, Reiner Z, Carbone F, Montecucco F, Sahebkar A
Biomolecules. 2019; 9(9).
PMID: 31455044
PMC: 6769786.
DOI: 10.3390/biom9090416.
Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.
Cervadoro A, Palomba R, Vergaro G, Cecchi R, Menichetti L, Decuzzi P
Front Bioeng Biotechnol. 2018; 6:177.
PMID: 30542650
PMC: 6277804.
DOI: 10.3389/fbioe.2018.00177.
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases.
Marrella A, Iafisco M, Adamiano A, Rossi S, Aiello M, Barandalla-Sobrados M
J R Soc Interface. 2018; 15(144).
PMID: 29997259
PMC: 6073647.
DOI: 10.1098/rsif.2018.0236.
Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.
Yu J, Li W, Yu D
Drug Des Devel Ther. 2018; 12:1697-1706.
PMID: 29928113
PMC: 6001834.
DOI: 10.2147/DDDT.S166749.
Drug Delivery and Nanoformulations for the Cardiovascular System.
Geldenhuys W, Khayat M, Yun J, Nayeem M
Res Rev Drug Deliv. 2017; 1(1):32-40.
PMID: 28713881
PMC: 5507069.